• 1
    Dorn CR, Taylor DON, Hibbard HH. Epizootiologic characteristics of canine and feline leukemia and lymphoma. Am J Vet Res 1967;28:9931001.
  • 2
    Schneider R. Comparison of age- and sex-specific incidence rate patterns of the leukemia complex in the cat and the dog. J Natl Cancer Inst 1983;70:971977.
  • 3
    Hardy WD jr. Hematopoietic tumors of cats. J Am Anim Hosp Assoc 1981;17:921940.
  • 4
    Mooney SC, Hayes AA, MacEwen EG, et al. Treatment and prognostic factors in lymphoma in cats: 103 cases (1977–1981). J Am Vet Med Assoc 1989;194:696699.
  • 5
    Vahlenkamp T, Müller H. FeLV-assozierte tumoren. In: KesslerM, ed. Kleintieronkologie. Diagnose un Therapie von Tumorerkran-kungen bei Hunden und Katzen. Berlin : Parey; 1999: 2127.
  • 6
    Vail DM, Moore AS, Ogilvie GK, Volk LM. Feline lymphoma (145 cases): Proliferation indices, cluster of differentiation 3 immu-noreactivity, and their association with prognosis in 90 cats. J Vet Intern Med 1998; 12:349354.
  • 7
    Mooney SC, Hayes AA. Lymphoma in the cat: An approach to diagnosis and management. Semin Vet Med Surg (Small Anim) 1986; 1:5157.
  • 8
    Valli VE, Jacobs RM, Norris A, et al. The histologic classification of 602 cases of feline lymphoproliferative disease using the National Cancer Institute working formulation. J Vet Diagn Invest 2000; 12: 295306.
  • 9
    Cockerell GL, Krakowka S, Hoover EA, et al. Characterization of feline T- and B-lymphocytes and identification of an experimental induced T-cell neoplasm in the cat. J Natl Cancer Inst 1976;57:907913.
  • 10
    Hardy WD Jr, Zukerman EE, MacEwen EG, et al. A feline leukemia virus and sarcoma virus-induced tumor-specific antigen. Nature (London) 1977;270:249251.
  • 11
    Callanan JJ, Jones BA, Irvine J, et al. Histologic classification and immunophenotype of lymphosarcomas in cats with naturally and experimentally acquired feline immunodeficiency virus infections. Vet Pathol 1996;33:264272.
  • 12
    Holmberg CA, Manning JS, Osburn BI. Feline malignant lym-phomas: Comparison of morphologic and immunologic characteristics. Am J Vet Res 1976;37:14551460.
  • 13
    Cotter SM. Treatment of lymphoma and leukemia with cyclo-phosphamide, vincristine, and prednisone: II. Treatment of cats. J Am Anim Hosp Assoc 1983;19:166172.
  • 14
    Moore AS, Cotter SM, Frimberger AE, et al. A comparison of doxorubicin and COP for maintenance of remission in cats with lymphoma. J Vet Intern Med 1996; 10:372375.
  • 15
    Mooney SC, Hayes AA, Matus RE, MacEwen EG. Renal lymphoma in cats: 28 cases (1977–1984). J Am Vet Med Assoc 1987; 191:14731477.
  • 16
    Kristal O, Lana SE, Ogilvie GK, et al. Single agent chemotherapy with doxorubicin for feline lymphoma: A retrospective study of 19 cases (1994–1997). J Vet Intern Med 2001;15:125130.
  • 17
    Weijer K, UytdeHaag F, Osterhaus A. Control of feline leukemia virus infection by a removal programme. Vet Rec 1986;119:555556.
  • 18
    Cotter SM, Essex M. Animal model: Feline acute lymphoblastic leukemia and plastic anemia. Am J Pathol 1977;87:265268.
  • 19
    Jarrett WFH. Some illustrative systems of viral carcinogenesis: The feline leukemia virus. In: SymingtonT, CarterRL, ed. Scientific Foundations of Oncology. Chicago , IL : Year Book Medical Publishers Inc; 1976: 393403.
  • 20
    Court EA, Watson ADJ, Peaston AE. Retrospective study of 60 cases of feline lymphosarcoma. Aust Vet J 1997;75:424427.
  • 21
    Cotter SM, Hardy WD Jr, Essex M. The association of the feline leukemia virus with lymphosarcoma and other disorders in the cat. J Am Vet Med Assoc 1975; 166:449454.
  • 22
    Jeglum KA, Whereat A, Young K. Chemotherapy of lymphoma in 75 cats. J Am Vet Med Assoc 1987;190:174178.
  • 23
    Hartmann K, Gerle K, Leutenegger C, Jarret O. Feline leukemia virus. Most important oncogene in cats? Proceedings Fourth International Feline Retrovirus Research Symposium, Glasgow, May 27–30, 1998:3g.
  • 24
    Jackson ML, Haines DM, Meric SM, et al. Feline leukemia virus detection by immunohistochemistry and polymerase chain reaction in formalin-fixed, paraffin-embedded tumor tissue from cats with lymphosarcoma. Can J Vet Res 1993;57:269276.
  • 25
    Gabor LJ, Malik R, Canfield PJ. Clinical and anatomical features of lymphosarcoma in 118 cats. Aust Vet J 1998;76:725732.
  • 26
    Peaston AE, Maddison JE. Efficacy of doxorubicin as an induction agent for cats with lymphosarcoma. Aust Vet J 1999;77:442444.
  • 27
    Moore AS, Ruslander D, Cotter SM, et al. Efficacy of, and toxicosis associated with, oral idarubicin administration in cats with neoplasia. J Am Vet Med Assoc 1995;206:15501554.
  • 28
    Mahony OM, Moore AS, Cotter SM, et al. Alimentary lymphoma in cats: 28 cases (1988–1993). J Am Vet Med Assoc 1995; 207:15931598.
  • 29
    Zwahlen CH, Lucroy MD, Kraegel SA, Madewell BR. Results of chemotherapy for cats with alimentary malignant lymphoma: 21 cases (1993–1997). J Am Vet Med Assoc 1998;213:11441149.
  • 30
    Klein MK, Powers BE, Calley C, et al. Feline nasal lymphoma: A retrospective analysis. Proceedings 15th Annual Conference of the Veterinary Cancer Society, Tucson, AZ, 1995: 7980.
  • 31
    Mauldin GE, Mooney SC, Meleo KA, et al. Chemotherapy in 132 cats with lymphoma: 1988–1994. Proceedings 15th Annual Conference of the Veterinary Cancer Society, Tucson, AZ, 1995.